Seattle Genetics to Host Conference Call and Webcast on September 13, 2010 to Discuss Top-line Data from Lintuzumab (SGN-33) Ph

Show Health and Fitness Publications

Wed, September 22, 2010

[ Wed, Sep 22nd 2010 ] - Market Wire

Edge Healthcare Partners, LLC Advises Gentiva Hea .. viously Announced Acquisition of Odyssey HealthCa

[ Wed, Sep 22nd 2010 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present at the JMP Healthcare Conference

[ Wed, Sep 22nd 2010 ] - Market Wire

Medtronica?s Resolute Drug-Eluting Stent Shows Strong Performance in Second aAll Comersa? Study

[ Wed, Sep 22nd 2010 ] - Market Wire

St. Jude Medical to Showcase New Lesion Assessment Technology at TCT 2010

[ Wed, Sep 22nd 2010 ] - Market Wire

Valeant and Biovail Announce Valeanta?s Intention .. d to Valeant Stockholders upon Obtaining Sharehol

[ Wed, Sep 22nd 2010 ] - Market Wire

Aeterna Zentaris to Present at Upcoming Sachs 10t .. l Biotech Europe Investment Forum on September 29

[ Wed, Sep 22nd 2010 ] - Market Wire

Zalicus to Present at the Fifth Annual JMP Securities Healthcare Conference

Tue, September 21, 2010

[ Tue, Sep 21st 2010 ] - Market Wire

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Baxter International Inc.

[ Tue, Sep 21st 2010 ] - Market Wire

DIAGNOCURE';S PCA3 PROSTATE CANCER BIOMARKER SUBM .. EN-PROBE TO THE U.S. FOOD AND DRUG ADMINISTRATION

[ Tue, Sep 21st 2010 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of Otix Global, Inc.

[ Tue, Sep 21st 2010 ] - Market Wire

St. Jude Medical anuncia aprobacin europea de pro .. Athena para la gestin de tratamientos de estimula

[ Tue, Sep 21st 2010 ] - Market Wire

Progenics Announces Clinical Completion of Subcut .. fety Study in Chronic Non-Malignant Pain Patients

[ Tue, Sep 21st 2010 ] - Market Wire

Roche's E-Plate VIEW Joins Impedance-based Real-time Monitoring with Visual Inspection of Cells

[ Tue, Sep 21st 2010 ] - Market Wire

Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Exact Sciences to Present at JMP Securities Healthcare Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Salix Pharmaceuticals to Present at JMP Conference

[ Tue, Sep 21st 2010 ] - Market Wire

Celera Announces Issuance of United States Patent .. nt as a Predictor of Increased Risk of Myocardial

[ Tue, Sep 21st 2010 ] - Market Wire

BioCryst to Present At JMP Securities Healthcare Conference

[ Tue, Sep 21st 2010 ] - Market Wire

ImmunoGen, Inc. Announces Start of SAR566658 Clinical Testing

[ Tue, Sep 21st 2010 ] - Market Wire

Cardiac Science Launches Cambridge Hearta?s Micro .. lternans (MTWA) Technology in Stress Test Systems

[ Tue, Sep 21st 2010 ] - Market Wire

DaVita Announces Refinancing of Existing Indebtedness and Estimate of Third Quarter Earnings

Mon, September 20, 2010

[ Mon, Sep 20th 2010 ] - Market Wire

Enzo Biochem Streamlines Operations; Expects Positive Operating Cash Flow in 2011

[ Mon, Sep 20th 2010 ] - Market Wire

Tenet Announces St. Christophera?s Hospital for Children Appoints New Hospital CEO

[ Mon, Sep 20th 2010 ] - Market Wire

CompCare Retains KCSA Strategic Communications for Investor Relations

[ Mon, Sep 20th 2010 ] - Market Wire

Annals of Thoracic Surgery Publishes U.S. Registr .. ts for Abiomed AB5000a" Ventricular Assist Device

[ Mon, Sep 20th 2010 ] - Market Wire

ZIOPHARM Oncology to Present at the JMP Healthcare Conference

[ Mon, Sep 20th 2010 ] - Market Wire

Health Net Selected as a Top Military Spouse Friendly Employer

[ Mon, Sep 20th 2010 ] - Market Wire

Celldex Therapeutics Announces Initiation of Rand .. inical Trial of CDX-011 in Advanced Breast Cancer

[ Mon, Sep 20th 2010 ] - Market Wire

St. Jude Medical gibt europische Zulassung des At .. en Generation zum Management von Tiefenhirnstimul

[ Mon, Sep 20th 2010 ] - Market Wire

LifePoint Hospitals, Inc. Announces Proposed Offering of $400 Million of Senior Notes

[ Mon, Sep 20th 2010 ] - Market Wire

Micromet Initiates Phase 2 Trial of Blinatumomab .. Relapsed/Refractory Acute Lymphoblastic Leukemia

[ Mon, Sep 20th 2010 ] - Market Wire

Micromet Initiates European Pivotal Trial of Blin .. Adult Patients with Acute Lymphoblastic Leukemia

[ Mon, Sep 20th 2010 ] - Market Wire

Celera Signs Agreement with Abbott for Distributi .. Identify Patients at Risk of Coronary Heart Disea

[ Mon, Sep 20th 2010 ] - Market Wire

Prestige Brands Holdings, Inc. Announces Agreement to Acquire Blacksmith Brands

[ Mon, Sep 20th 2010 ] - Market Wire

24-Week Phase 3 Study Found Investigational Drug .. ylated Hemoglobin (HbA1c) When Added to Glimepiri

Fri, September 17, 2010

[ Fri, Sep 17th 2010 ] - Market Wire

UnitedHealth Group, Humana, HealthSpring and Universal American

[ Fri, Sep 17th 2010 ] - Market Wire

Ramius Sends Letter to Independent Board Members of Cypress

[ Fri, Sep 17th 2010 ] - Market Wire

Medtronic Showcases Cardiovascular Devices at TCT 2010

[ Fri, Sep 17th 2010 ] - Market Wire

Emergent BioSolutions Awarded HHS Contract Valued .. to $186.6 Million to Develop rPA Anthrax Vaccine

[ Fri, Sep 17th 2010 ] - Market Wire

Newly Published Data Show Occipital Nerve Stimula .. y Be a Promising New Therapy for Chronic Migraine

[ Fri, Sep 17th 2010 ] - Market Wire

CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study

[ Fri, Sep 17th 2010 ] - Market Wire

AUSTRALIA';S CANBERRA HOSPITAL UNVEILS IMRISneuro SUITE

[ Fri, Sep 17th 2010 ] - Market Wire

Health Net Sponsors the 3rd National Veterans Summer Sports Clinic in San Diego

[ Fri, Sep 17th 2010 ] - Market Wire

Ligand Enters into Agreement with Proximagen for CXCR4 Target

[ Fri, Sep 17th 2010 ] - Market Wire

Response Genetics, Inc. Settles Proxy Contest With Special Situations Fund

[ Fri, Sep 17th 2010 ] - Market Wire

Data to Be Presented at ERS Conference Highlights .. enefit Cystic Fibrosis Patients on Minimal Pharma

Thu, September 16, 2010

[ Thu, Sep 16th 2010 ] - Market Wire

Osiris Therapeutics to Present at UBS Global Life Sciences Conference

[ Thu, Sep 16th 2010 ] - Market Wire

Community Health Systems Announces New 4 Million Share Open Market Share Repurchase

[ Thu, Sep 16th 2010 ] - Market Wire

Aetna Signs Contract Extension with University of Pennsylvania Health System

[ Thu, Sep 16th 2010 ] - Market Wire

CYTOGENIX, INC. Schedules Shareholder's Conference Call on September 22nd

[ Thu, Sep 16th 2010 ] - Market Wire

Abiomed Showcases Impella® Technology at TCT 201 .. eakfast Series Featuring USpella and Case Reviews

[ Thu, Sep 16th 2010 ] - Market Wire

Healthways Announces Achievements in Medicare Health Support; Other Seniorsa? Programs

[ Thu, Sep 16th 2010 ] - Market Wire

Medtronic Receives European CE Mark Approval for .. Brain Stimulation Therapy for Refractory Epilepsy

[ Thu, Sep 16th 2010 ] - Market Wire

Cellular Dynamics International, ACEA Biosciences .. Cooperate to Evaluate iCell Cardiomyocytes on the

[ Thu, Sep 16th 2010 ] - Market Wire

NPS Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Sep 16th 2010 ] - Market Wire

ImmunoCellular Therapeutics Selects Averion Inter .. onal Corp. to Conduct Phase II Glioblastoma Study

[ Thu, Sep 16th 2010 ] - Market Wire

Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g

[ Thu, Sep 16th 2010 ] - Market Wire

GTx Announces Corporate Presentation at the UBS Global Life Sciences Conference

[ Thu, Sep 16th 2010 ] - Market Wire

Alkermes Stock Trading Halted Today

[ Thu, Sep 16th 2010 ] - Market Wire

BioCryst Reports Positive Results From A Phase 2 .. 8 Combined with Allopurinol in Patients with Gout

Wed, September 15, 2010

[ Wed, Sep 15th 2010 ] - Market Wire

Gileads HIV-Einzeltablette, das aQuada-Prparat, z .. 8-wchiger Phase-II-Studie hohe virale Suppression

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien maakt hoogtepunten beleggersvergadering bekend

[ Wed, Sep 15th 2010 ] - Market Wire

Qtrax Beta Available in India

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien Anuncia Destaques da Assembl©ia de Investidores

[ Wed, Sep 15th 2010 ] - Market Wire

Forest Laboratories, Inc. Finalizes Previously Di .. vernment Investigations and Related Civil Qui Tam

[ Wed, Sep 15th 2010 ] - Market Wire

Crozer-Keystone Health System Joins Aetna Better Health Network

[ Wed, Sep 15th 2010 ] - Market Wire

Bond Labs Expands Resurrection(TM) into the Atlanta and Savannah Markets

[ Wed, Sep 15th 2010 ] - Market Wire

BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting

[ Wed, Sep 15th 2010 ] - Market Wire

Celgene Corporation to Present at the UBS 2010 Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

Medical Action Industries to Present in the 2010 UBS Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

ArthroCare to Present at UBS Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

BioCryst Reports Results from Two Forodesine Oncology Studies

[ Wed, Sep 15th 2010 ] - Market Wire

SuperGen to Present at UBS Global Life Sciences Conference on September 22nd

[ Wed, Sep 15th 2010 ] - Market Wire

Four Rivers Announces Licensure of STT Technology .. Gain, Reduction of Overhead Costs and Future Prof

Tue, September 14, 2010

[ Tue, Sep 14th 2010 ] - Market Wire

Law Offices of Howard G. Smith Announces Investig .. n On Behalf of Shareholders of ZymoGenetics, Inc.

[ Tue, Sep 14th 2010 ] - Market Wire

Human Genome Sciences Invites Investors to Listen .. entation at Stifel Nicolaus Healthcare Conference

[ Tue, Sep 14th 2010 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of

[ Tue, Sep 14th 2010 ] - Market Wire

Alexion to Present at the UBS Global Life Sciences Conference

[ Tue, Sep 14th 2010 ] - Market Wire

Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence

[ Tue, Sep 14th 2010 ] - Market Wire

Guided Therapeutics Completes $3 Million Financing

[ Tue, Sep 14th 2010 ] - Market Wire

Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference

[ Tue, Sep 14th 2010 ] - Market Wire

Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month

[ Tue, Sep 14th 2010 ] - Market Wire

Zalicus To Present at the Rodman & Renshaw Annual Global Investment Conference NYC

[ Tue, Sep 14th 2010 ] - Market Wire

Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010

[ Tue, Sep 14th 2010 ] - Market Wire

Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010

[ Tue, Sep 14th 2010 ] - Market Wire

CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS

[ Tue, Sep 14th 2010 ] - Market Wire

AngioDynamics Strengthens Executive Team with Key Appointments

[ Tue, Sep 14th 2010 ] - Market Wire

Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer

Mon, September 13, 2010

[ Mon, Sep 13th 2010 ] - Market Wire

Il regime quadruplo a monosomministrazione giorna .. 'HIV di Gilead consente il mantenimento di una so

[ Mon, Sep 13th 2010 ] - Market Wire

A New Audio Interview Featuring Frank Mir, Director of Suffer Apparel, is Now at SmallCapVoice.com

[ Mon, Sep 13th 2010 ] - Market Wire

Allos Therapeutics to Present at Upcoming Investor Conferences

[ Mon, Sep 13th 2010 ] - Market Wire

Biomagnetics Moves Zhuhai Oil Energy Acquisition .. t Phase - Expects Closing During CEO Trip to Chin

[ Mon, Sep 13th 2010 ] - Market Wire

PerkinElmer to Present at UBS Global Life Science Conference

[ Mon, Sep 13th 2010 ] - Market Wire

ARIAD Announces Initiation of Ponatinib (AP24534) .. -Resistant or Intolerant Chronic Myeloid Leukemia

[ Mon, Sep 13th 2010 ] - Market Wire

Pro-Pharmaceuticals Collaborates with Numoda to M .. l Trial to Increase Speed-to-Market for DAVANAT®

[ Mon, Sep 13th 2010 ] - Market Wire

Geron Obtains Exclusive License for Deriving Cart .. Embryonic Stem Cells from University of Edinburgh

[ Mon, Sep 13th 2010 ] - Market Wire

Forest Responds to FDA Complete Response Letter for Roflumilast

[ Mon, Sep 13th 2010 ] - Market Wire

UnitedHealth Group Named to Dow Jones Sustainabil .. erica and World Indices for 12th Consecutive Year

[ Mon, Sep 13th 2010 ] - Market Wire

XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity

[ Mon, Sep 13th 2010 ] - Market Wire

LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics

[ Mon, Sep 13th 2010 ] - Market Wire

Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference

Sun, September 12, 2010

[ Sun, Sep 12th 2010 ] - Market Wire

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

Fri, September 10, 2010

[ Fri, Sep 10th 2010 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. Discuss Top-line Data from Lintuzumab (SGN-33) Ph

[ Fri, Sep 10th 2010 ] - Market Wire

ISS Recommends That Response Genetics Shareholder .. Gold Proxy Card to Re-Elect Experienced Directors

[ Fri, Sep 10th 2010 ] - Market Wire

Fitch Affirms CareFusion Corporation's Ratings at 'BBB'; Outlook Stable

[ Fri, Sep 10th 2010 ] - Market Wire

Advanced Cell Technology to Present at the 12th A .. ual Rodman & Renshaw Global Investment Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Orthovita to Present at the UBS Global Life Sciences Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Medtronic Releases 2010 Corporate Citizenship Report

[ Fri, Sep 10th 2010 ] - Market Wire

Teva to Present at the Morgan Stanley Global Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Cubist Pharmaceuticalsa? Antibiotic Programs Featured in 47 Presentations at 50th ICAAC

[ Fri, Sep 10th 2010 ] - Market Wire

ArQule, Inc. to Present at Stifel Nicolaus and UBS Conferences

[ Fri, Sep 10th 2010 ] - Market Wire

PerkinElmer to Present at Stifel Nicolaus Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Orthofix International to Participate inStifel Nicolaus 2010 Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Pro-Pharmaceuticalsa? Presentation at Rodman and .. l Global Investment Conference to Be Webcast Live

[ Fri, Sep 10th 2010 ] - Market Wire

Bioniche Reports Fiscal 2010 Year-End Results

Thu, September 9, 2010

[ Thu, Sep 09th 2010 ] - Market Wire

Amedisys to Present at Two Upcoming Conferences

[ Thu, Sep 09th 2010 ] - Market Wire

Tenet Management to Speak at the Morgan Stanley Global Healthcare Conference on September 14, 2010

[ Thu, Sep 09th 2010 ] - Market Wire

Cohen Milstein Sellers & Toll PLLC Announces Class Action Lawsuit against Almost Family, Inc.

[ Thu, Sep 09th 2010 ] - Market Wire

Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences

[ Thu, Sep 09th 2010 ] - Market Wire

Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET

[ Thu, Sep 09th 2010 ] - Market Wire

CIGNA Announces Appearance at the Morgan Stanley Global Healthcare Conference

[ Thu, Sep 09th 2010 ] - Market Wire

Elan Statement Regarding Shareholder Call

[ Thu, Sep 09th 2010 ] - Market Wire

Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. an &; Renshaw Annual Global Investment Conference

[ Thu, Sep 09th 2010 ] - Market Wire

AngioDynamics to Participate At Upcoming Investor Conferences

[ Thu, Sep 09th 2010 ] - Market Wire

CombinatoRx Changes Company Name to Zalicus Inc.

[ Thu, Sep 09th 2010 ] - Market Wire

Salix Pharmaceuticals to Present at Stifel Nicolaus Conference

[ Thu, Sep 09th 2010 ] - Market Wire

Schiff Nutrition International, Inc. to Present a .. ing's 8th Best Ideas Conference on September 16th

[ Thu, Sep 09th 2010 ] - Market Wire

Schiff Nutrition International, Inc. Announces Timing of Fiscal 2011 First Quarter Results

Wed, September 8, 2010

[ Wed, Sep 08th 2010 ] - Market Wire

YM BioSciences announces positive results from CY .. se I study published in British Journal of Cancer

[ Wed, Sep 08th 2010 ] - Market Wire

Hi-Tech Pharmacal Reports Sales of $40.4 Million .. EPS of $0.67 for the Quarter Ended July 31, 2010

[ Wed, Sep 08th 2010 ] - Market Wire

Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against SciClone Pharmaceuticals, Inc.

[ Wed, Sep 08th 2010 ] - Market Wire

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

Kindred Healthcare to Participate in the Stifel Nicolaus 2010 Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results

[ Wed, Sep 08th 2010 ] - Market Wire

FDA Advisory Committee Recommends Approval of For .. e Fosamil for the Treatment of Community Acquired

[ Wed, Sep 08th 2010 ] - Market Wire

AGA Medical to Present at the Baird 2010 Health Care Conference

[ Wed, Sep 08th 2010 ] - Market Wire

PPD Establishes Network of Sites for Conducting Phase I Trials in Patients

[ Wed, Sep 08th 2010 ] - Market Wire

Health Management Associates, Inc. to Present at the Morgan Stanley Global Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

65% of People Whose Prior Treatment for Hepatitis .. SVR (Viral Cure) with Telaprevir-Based Therapy in

[ Wed, Sep 08th 2010 ] - Market Wire

Resurrectiona" Showcased to NYC at the Attica 2 Year Anniversary Party

Tue, September 7, 2010

[ Tue, Sep 07th 2010 ] - Market Wire

Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone® Litigation

[ Tue, Sep 07th 2010 ] - Market Wire

Array BioPharma to Present at the Rodman & Rensha .. nce and the Stifel Nicolaus Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

La Jolla Pharmaceutical Company Provides Update o .. ch for Clinical Products to In-License or Acquire

[ Tue, Sep 07th 2010 ] - Market Wire

Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

BioSante Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Health Net Federal Services Meets Target Enrollme .. Chronic Obstructive Pulmonary Disease Management

[ Tue, Sep 07th 2010 ] - Market Wire

CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer

[ Tue, Sep 07th 2010 ] - Market Wire

Somaxon Pharmaceuticals Announces Commercial Availability of Silenor

[ Tue, Sep 07th 2010 ] - Market Wire

Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Response Genetics, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Rosetta Genomics to Present at the Rodman & Renshaw 12th Annual Global Investment Conference

[ Tue, Sep 07th 2010 ] - Market Wire

BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development

[ Tue, Sep 07th 2010 ] - Market Wire

SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th

Sat, September 4, 2010

[ Sat, Sep 04th 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., anteriormente profeso .. on Cancer Center, se incorpora a Health Discovery

[ Sat, Sep 04th 2010 ] - Market Wire

Transdel Pharmaceuticals

[ Sat, Sep 04th 2010 ] - Market Wire

Curis to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

[ Sat, Sep 04th 2010 ] - Market Wire

Wright Medical Group, Inc. to Participate in Upcoming September 2010 Healthcare Conferences

[ Sat, Sep 04th 2010 ] - Market Wire

Aetna Reminds Members Affected by Hurricane Earl Where to Call for Help

[ Sat, Sep 04th 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., ehemaliger Professor .. nderson Cancer Center tritt Health Discovery Corp

[ Sat, Sep 04th 2010 ] - Market Wire

UnitedHealth Group to Support Members Affected by Hurricane Earl

Fri, September 3, 2010

[ Fri, Sep 03rd 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., cientista e antigo pr .. o do Anderson Cancer Center, junta-se a Health Di

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences presenta alla?Agenzia Europea per .. torizzazione per la?immissione in commercio delle

[ Fri, Sep 03rd 2010 ] - Market Wire

ImmunoCellular Therapeutics Issues Letter to Shareholders

[ Fri, Sep 03rd 2010 ] - Market Wire

Life Technologies to Present at the UBS Global Life Sciences Conference

[ Fri, Sep 03rd 2010 ] - Market Wire

American Learning Corporation to Appeal Nasdaq Delisting Notice

[ Fri, Sep 03rd 2010 ] - Market Wire

KCI?????LifeCella" ???Novadaq Technologies????????????SPY®????????????

[ Fri, Sep 03rd 2010 ] - Market Wire

/C O R R E C T I O N - Mindray Medical International Limited /

[ Fri, Sep 03rd 2010 ] - Market Wire

MDS to Release Third Quarter 2010 Financial Results

[ Fri, Sep 03rd 2010 ] - Market Wire

Tibotec Pharmaceuticals Seeks European Marketing .. r Investigational Once-Daily HIV Treatment TMC278

[ Fri, Sep 03rd 2010 ] - Market Wire

Medisafe 1 Technologies Clarifies the PR Issued o .. ividend, as a Forward Split of 5-1 in the Form of

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences Submits European Marketing Applic .. blet Regimen of Truvada® and TMC278 for the Trea

[ Fri, Sep 03rd 2010 ] - Market Wire

Alcon Launches AcrySof® IQ ReSTOR® Toric Intraocular Lens Outside the United States

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences dient aanvraag in voor Europese m .. van ©©n tablet per dag van Truvada en TMC278 t

Thu, September 2, 2010

[ Thu, Sep 02nd 2010 ] - Market Wire

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.

[ Thu, Sep 02nd 2010 ] - Market Wire

BRINAVESSa" (vernakalant) per infusione approvato .. conversione rapida della fibrillazione atriale di

[ Thu, Sep 02nd 2010 ] - Market Wire

BioDelivery Sciences Announces Positive Meeting w .. eamlined ONSOLIS REMS with Broadened Distribution

[ Thu, Sep 02nd 2010 ] - Market Wire

KCIa?s LifeCell Corporation en Novadaq Technologi .. verkoop- en marketingovereenkomst voor exclusieve

[ Thu, Sep 02nd 2010 ] - Market Wire

Cardiome Achieves $30 Million Milestone

[ Thu, Sep 02nd 2010 ] - Market Wire

Oncolytics Biotech(R) Inc. Announces Randomized P .. to be Conducted by the Gynecologic Oncology Group

[ Thu, Sep 02nd 2010 ] - Market Wire

Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010

[ Thu, Sep 02nd 2010 ] - Market Wire

MedPro Safety Products Completes Royalty Monetization Transaction

[ Thu, Sep 02nd 2010 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September

[ Thu, Sep 02nd 2010 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at Several Upcoming Investment Conferences

[ Thu, Sep 02nd 2010 ] - Market Wire

Gilead geeft update over aandelenterugkoop van 5 miljard dollar

[ Thu, Sep 02nd 2010 ] - Market Wire

Transdel Pharmaceuticals Presents Phase 3 Study D .. sdel® at World Pain Congress in Montreal, Canada

[ Thu, Sep 02nd 2010 ] - Market Wire

La divisione di KCI LifeCella" Corporation e Nova .. contratto di vendita e marketing per la distribu

Wed, September 1, 2010

[ Wed, Sep 01st 2010 ] - Market Wire

Gilead presenta ltimos datos sobre programa de recompra de acciones por valor de $5.000 millones

[ Wed, Sep 01st 2010 ] - Market Wire

Health Net Strives to Exceed $75,000 Goal Through Annual Golf Classic Despite Hard Economic Times

[ Wed, Sep 01st 2010 ] - Market Wire

SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS

[ Wed, Sep 01st 2010 ] - Market Wire

Navigant Capital Advisors, LLC Serves as Financia .. Health Systems, Inc. in Its $156.8 Million Sale t

[ Wed, Sep 01st 2010 ] - Market Wire

Amerigroup Launches 24/7 Nurse Pilot Program: A First for Tennessee

[ Wed, Sep 01st 2010 ] - Market Wire

Amerigroup Launches 24/7 Nurse Pilot Program: A First for Maryland

[ Wed, Sep 01st 2010 ] - Market Wire

Kim A. Keck to Lead Aetnaa?s Middle Markets Business

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien Announces Investor Meeting Agenda

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien annuncia il programma della riunione degli investitori

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien gibt Tagesordnung seiner Investorenversammlung bekannt

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien divulga programa da reunio com investidores

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien annonce l'agenda de sa r©union avec les investisseurs

[ Wed, Sep 01st 2010 ] - Market Wire

GenMark Diagnostics Appoints James Fox, Ph.D., to Board of Directors

Seattle Genetics to Host Conference Call and Webcast on September 13, 2010 to Discuss Top-line Data from Lintuzumab (SGN-33) Ph

_{//health-fitness.news-articles.net/content/2010/ .. uss-top-line-data-from-lintuzumab-sgn-33-ph.html}
^{Published in Health and Fitness on Friday, September 10th 2010 at 13:26 GMT by Market Wire}

SEATTLE--([ BUSINESS WIRE ])--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that its management will host a conference call and webcast on Monday, September 13, 2010, at 5:30 a.m. Pacific Time (PT) / 8:30 a.m. Eastern Time (ET) to discuss top-line results from its lintuzumab (SGN-33) phase IIb clinical trial in acute myeloid leukemia (AML).

The live event will be available from Seattle Geneticsa� website at [ www.seattlegenetics.com ], under the Investors and News section, or by calling (877) 941-8631 (domestic) or (480) 629-9819 (international). The access code is 4364358. A replay of the discussion will be available beginning at approximately 7:00 a.m. PT / 10:00 a.m. ET on September 13, 2010 from Seattle Geneticsa� website or by calling (800) 406-7325 (domestic) or (303) 590-3030 (international), using access code 4364358. The replay will be available through September 17, 2010.

About Seattle Genetics

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The companya�s lead product candidate, brentuximab vedotin (SGN-35), is in a pivotal trial under a Special Protocol Assessment with the U.S. Food and Drug Administration. Brentuximab vedotin is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has five other clinical-stage programs: lintuzumab (SGN-33), dacetuzumab (SGN-40), SGN-70, SGN-75 and ASG-5ME. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as an ADC co-development agreement with Agensys, an affiliate of Astellas. More information can be found at [ www.seattlegenetics.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire